Predictors for early HBeAg loss during lamivudine therapy in HBeAg-positive chronic hepatitis B patients with acute exacerbation

Lignende værker

• Effect of lamivudine in HBeAg-positive chronic hepatitis B: Discordant effect on HBeAg and HBV DNA according to pretreatment ALT level
  af: Kurihara, Tomoko, et al.
  Udgivet: (2005)
• HBsAg as an important predictor of HBeAg seroconversion following antiviral treatment for HBeAg-positive chronic hepatitis B patients
  af: Yang, Jiezuan, et al.
  Udgivet: (2014)
• Study of hepatic histomorphology in HBeAg+ and HBeAg− patients with CHB: Experience from Bangladesh
  af: Ayub Al Mamun, et al.
  Udgivet: (2013-01-01)
• Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers
  af: Lim, Chee Kent, et al.
  Udgivet: (2006)
• Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
  af: Piratvisuth, Teerha, et al.
  Udgivet: (2008)